Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma

Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC

Detalles Bibliográficos
Autores principales: Morobeid, Heba, Pizarro, Carmen, Biener, Leonie, Ulrich-Merzenich, Gudrun, Kütting, Daniel, Nickenig, Georg, Skowasch, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365141/
https://www.ncbi.nlm.nih.gov/pubmed/34409092
http://dx.doi.org/10.1183/23120541.00190-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365141/
https://www.ncbi.nlm.nih.gov/pubmed/34409092
http://dx.doi.org/10.1183/23120541.00190-2021

Ejemplares similares